We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care.
- Authors
Gryczynski, Jan; Sanchez, Katherine; Carswell, Steven B.; Schwartz, Robert P.
- Abstract
Background: The TAPS Tool ("Tobacco, Alcohol, Prescription drug, and illicit Substance use") is a screening and brief assessment for detecting unhealthy substance use in healthcare settings that was developed by the National Institute on Drug Abuse Clinical Trials Network and validated in a multisite study. Our team developed a Spanish language version of the TAPS Tool that supports provider- and self-administration screening using a mobile/web-based platform, the TAPS Electronic Spanish Platform (TAPS-ESP). Methods: This article describes the protocol and rationale for a study to validate the TAPS-ESP in a sample of Spanish-speaking primary care patients recruited from a network of community-based clinics in Texas (target N = 1,000). The TAPS-ESP will be validated against established substance use disorder diagnostic measures, alternative screening tools, and substance use biomarkers. The study will subsequently examine barriers and facilitators to screening with the TAPS-ESP from a provider workflow perspective using qualitative interviews with providers. Discussion: Validating a Spanish language version of the TAPS Tool could expand access to evidence-based, linguistically accurate, and culturally relevant substance use screening and brief assessment for an underserved health disparity population. Trial registration: The study was registered with www.clinicaltrials.gov: NCT05476588, 07/22/2022.
- Subjects
TEXAS; NATIONAL Institute on Drug Abuse; PRIMARY care; HEALTH equity; SUBSTANCE abuse; MEDICAL screening; DRUGS; CLINICAL trial registries
- Publication
Addiction Science & Clinical Practice, 2023, Vol 18, Issue 1, p1
- ISSN
1940-0632
- Publication type
Article
- DOI
10.1186/s13722-023-00423-9